 | • レポートコード：GIR-105X14942 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、77ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、バルガンシクロビルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バルガンシクロビルの種類別市場規模（粉末、錠剤）、用途別市場規模（大人用、子供用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・バルガンシクロビルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Rakshit Drugs、United Biotech Private Limited、Roche ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：粉末、錠剤 ・用途別分析2016年-2026年：大人用、子供用 ・バルガンシクロビルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・バルガンシクロビルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・バルガンシクロビルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バルガンシクロビルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・バルガンシクロビルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Valganciclovir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Valganciclovir size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Valganciclovir market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Valganciclovir market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder
Tablet
Market segment by Application can be divided into
Adults
Children
The key market players for global Valganciclovir market are listed below:
Rakshit Drugs
United Biotech Private Limited
Roche
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Valganciclovir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Valganciclovir, with price, sales, revenue and global market share of Valganciclovir from 2019 to 2021.
Chapter 3, the Valganciclovir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Valganciclovir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Valganciclovir market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Valganciclovir sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Valganciclovir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Valganciclovir Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Powder
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Valganciclovir Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Valganciclovir Market Size & Forecast
1.4.1 Global Valganciclovir Sales in Value (2016-2026))
1.4.2 Global Valganciclovir Sales in Volume (2016-2026)
1.4.3 Global Valganciclovir Price by Type (2016-2026) & (USD/Unit)
1.5 Global Valganciclovir Production Capacity Analysis
1.5.1 Global Valganciclovir Total Production Capacity (2016-2026)
1.5.2 Global Valganciclovir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Valganciclovir Market Drivers
1.6.2 Valganciclovir Market Restraints
1.6.3 Valganciclovir Trends Analysis
2 Manufacturers Profiles
2.1 Rakshit Drugs
2.1.1 Rakshit Drugs Details
2.1.2 Rakshit Drugs Major Business
2.1.3 Rakshit Drugs Valganciclovir Product and Services
2.1.4 Rakshit Drugs Valganciclovir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 United Biotech Private Limited
2.2.1 United Biotech Private Limited Details
2.2.2 United Biotech Private Limited Major Business
2.2.3 United Biotech Private Limited Valganciclovir Product and Services
2.2.4 United Biotech Private Limited Valganciclovir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Valganciclovir Product and Services
2.3.4 Roche Valganciclovir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Valganciclovir Sales by Manufacturer
3.1 Global Valganciclovir Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Valganciclovir Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Valganciclovir
3.4 Market Concentration Rate
3.4.1 Top 3 Valganciclovir Manufacturer Market Share
3.4.2 Top 6 Valganciclovir Manufacturer Market Share
3.5 Global Valganciclovir Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Valganciclovir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Valganciclovir Market Size by Region
4.1.1 Global Valganciclovir Sales in Volume by Region (2016-2026)
4.1.2 Global Valganciclovir Revenue by Region (2016-2026)
4.2 North America Valganciclovir Revenue (2016-2026)
4.3 Europe Valganciclovir Revenue (2016-2026)
4.4 Asia-Pacific Valganciclovir Revenue (2016-2026)
4.5 South America Valganciclovir Revenue (2016-2026)
4.6 Middle East and Africa Valganciclovir Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Valganciclovir Sales in Volume by Type (2016-2026)
5.2 Global Valganciclovir Revenue by Type (2016-2026)
5.3 Global Valganciclovir Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Valganciclovir Sales in Volume by Application (2016-2026)
6.2 Global Valganciclovir Revenue by Application (2016-2026)
6.3 Global Valganciclovir Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Valganciclovir Sales by Type (2016-2026)
7.2 North America Valganciclovir Sales by Application (2016-2026)
7.3 North America Valganciclovir Market Size by Country
7.3.1 North America Valganciclovir Sales in Volume by Country (2016-2026)
7.3.2 North America Valganciclovir Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Valganciclovir Sales by Type (2016-2026)
8.2 Europe Valganciclovir Sales by Application (2016-2026)
8.3 Europe Valganciclovir Market Size by Country
8.3.1 Europe Valganciclovir Sales in Volume by Country (2016-2026)
8.3.2 Europe Valganciclovir Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Valganciclovir Sales by Type (2016-2026)
9.2 Asia-Pacific Valganciclovir Sales by Application (2016-2026)
9.3 Asia-Pacific Valganciclovir Market Size by Region
9.3.1 Asia-Pacific Valganciclovir Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Valganciclovir Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Valganciclovir Sales by Type (2016-2026)
10.2 South America Valganciclovir Sales by Application (2016-2026)
10.3 South America Valganciclovir Market Size by Country
10.3.1 South America Valganciclovir Sales in Volume by Country (2016-2026)
10.3.2 South America Valganciclovir Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Valganciclovir Sales by Type (2016-2026)
11.2 Middle East & Africa Valganciclovir Sales by Application (2016-2026)
11.3 Middle East & Africa Valganciclovir Market Size by Country
11.3.1 Middle East & Africa Valganciclovir Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Valganciclovir Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Valganciclovir Typical Distributors
12.3 Valganciclovir Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Valganciclovir Revenue by Type, (USD Million), 2021-2026
Table 2. Global Valganciclovir Revenue by Application, (USD Million), 2021-2026
Table 3. Rakshit Drugs Basic Information, Manufacturing Base and Competitors
Table 4. Rakshit Drugs Major Business
Table 5. Rakshit Drugs Valganciclovir Product and Services
Table 6. Rakshit Drugs Valganciclovir Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. United Biotech Private Limited Basic Information, Manufacturing Base and Competitors
Table 8. United Biotech Private Limited Major Business
Table 9. United Biotech Private Limited Valganciclovir Product and Services
Table 10. United Biotech Private Limited Valganciclovir Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Valganciclovir Product and Services
Table 14. Roche Valganciclovir Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Valganciclovir Sales by Manufacturer (2019-2021e) & (K Units)
Table 16. Global Valganciclovir Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Valganciclovir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Valganciclovir Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Valganciclovir Production Site of Key Manufacturer
Table 20. Valganciclovir New Entrant and Capacity Expansion Plans
Table 21. Valganciclovir Mergers & Acquisitions in the Past Five Years
Table 22. Global Valganciclovir Sales by Region (2016-2021e) & (K Units)
Table 23. Global Valganciclovir Sales by Region (2021-2026) & (K Units)
Table 24. Global Valganciclovir Revenue by Region (2016-2021e) & (USD Million)
Table 25. Global Valganciclovir Revenue by Region (2021-2026) & (USD Million)
Table 26. Global Valganciclovir Sales by Type (2016-2021e) & (K Units)
Table 27. Global Valganciclovir Sales by Type (2021-2026) & (K Units)
Table 28. Global Valganciclovir Revenue by Type (2016-2021e) & (USD Million)
Table 29. Global Valganciclovir Revenue by Type (2021-2026) & (USD Million)
Table 30. Global Valganciclovir Price by Type (2016-2021e) & (USD/Unit)
Table 31. Global Valganciclovir Price by Type (2021-2026) & (USD/Unit)
Table 32. Global Valganciclovir Sales by Application (2016-2021e) & (K Units)
Table 33. Global Valganciclovir Sales by Application (2021-2026) & (K Units)
Table 34. Global Valganciclovir Revenue by Application (2016-2021e) & (USD Million)
Table 35. Global Valganciclovir Revenue by Application (2021-2026) & (USD Million)
Table 36. Global Valganciclovir Price by Application (2016-2021e) & (USD/Unit)
Table 37. Global Valganciclovir Price by Application (2021-2026) & (USD/Unit)
Table 38. North America Valganciclovir Sales by Country (2016-2021e) & (K Units)
Table 39. North America Valganciclovir Sales by Country (2021-2026) & (K Units)
Table 40. North America Valganciclovir Revenue by Country (2016-2021e) & (USD Million)
Table 41. North America Valganciclovir Revenue by Country (2021-2026) & (USD Million)
Table 42. North America Valganciclovir Sales by Type (2016-2021e) & (K Units)
Table 43. North America Valganciclovir Sales by Type (2021-2026) & (K Units)
Table 44. North America Valganciclovir Sales by Application (2016-2021e) & (K Units)
Table 45. North America Valganciclovir Sales by Application (2021-2026) & (K Units)
Table 46. Europe Valganciclovir Sales by Country (2016-2021e) & (K Units)
Table 47. Europe Valganciclovir Sales by Country (2021-2026) & (K Units)
Table 48. Europe Valganciclovir Revenue by Country (2016-2021e) & (USD Million)
Table 49. Europe Valganciclovir Revenue by Country (2021-2026) & (USD Million)
Table 50. Europe Valganciclovir Sales by Type (2016-2021e) & (K Units)
Table 51. Europe Valganciclovir Sales by Type (2021-2026) & (K Units)
Table 52. Europe Valganciclovir Sales by Application (2016-2021e) & (K Units)
Table 53. Europe Valganciclovir Sales by Application (2021-2026) & (K Units)
Table 54. Asia-Pacific Valganciclovir Sales by Region (2016-2021e) & (K Units)
Table 55. Asia-Pacific Valganciclovir Sales by Region (2021-2026) & (K Units)
Table 56. Asia-Pacific Valganciclovir Revenue by Region (2016-2021e) & (USD Million)
Table 57. Asia-Pacific Valganciclovir Revenue by Region (2021-2026) & (USD Million)
Table 58. Asia-Pacific Valganciclovir Sales by Type (2016-2021e) & (K Units)
Table 59. Asia-Pacific Valganciclovir Sales by Type (2021-2026) & (K Units)
Table 60. Asia-Pacific Valganciclovir Sales by Application (2016-2021e) & (K Units)
Table 61. Asia-Pacific Valganciclovir Sales by Application (2021-2026) & (K Units)
Table 62. South America Valganciclovir Sales by Country (2016-2021e) & (K Units)
Table 63. South America Valganciclovir Sales by Country (2021-2026) & (K Units)
Table 64. South America Valganciclovir Revenue by Country (2016-2021e) & (USD Million)
Table 65. South America Valganciclovir Revenue by Country (2021-2026) & (USD Million)
Table 66. South America Valganciclovir Sales by Type (2016-2021e) & (K Units)
Table 67. South America Valganciclovir Sales by Type (2021-2026) & (K Units)
Table 68. South America Valganciclovir Sales by Application (2016-2021e) & (K Units)
Table 69. South America Valganciclovir Sales by Application (2021-2026) & (K Units)
Table 70. Middle East & Africa Valganciclovir Sales by Country (2016-2021e) & (K Units)
Table 71. Middle East & Africa Valganciclovir Sales by Country (2021-2026) & (K Units)
Table 72. Middle East & Africa Valganciclovir Revenue by Country (2016-2021e) & (USD Million)
Table 73. Middle East & Africa Valganciclovir Revenue by Country (2021-2026) & (USD Million)
Table 74. Middle East & Africa Valganciclovir Sales by Type (2016-2021e) & (K Units)
Table 75. Middle East & Africa Valganciclovir Sales by Type (2021-2026) & (K Units)
Table 76. Middle East & Africa Valganciclovir Sales by Application (2016-2021e) & (K Units)
Table 77. Middle East & Africa Valganciclovir Sales by Application (2021-2026) & (K Units)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Valganciclovir Typical Distributors
Table 81. Valganciclovir Typical Customers
List of Figures
Figure 1. Valganciclovir Picture
Figure 2. Global Valganciclovir Sales Market Share by Type in 2020
Figure 3. Powder
Figure 4. Tablet
Figure 5. Global Valganciclovir Sales Market Share by Application in 2020
Figure 6. Adults
Figure 7. Children
Figure 8. Global Valganciclovir Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Valganciclovir Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Valganciclovir Sales (2016-2026) & (K Units)
Figure 11. Global Valganciclovir Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Valganciclovir Production Capacity (2016-2026) & (K Units)
Figure 13. Global Valganciclovir Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Valganciclovir Market Drivers
Figure 15. Valganciclovir Market Restraints
Figure 16. Valganciclovir Market Trends
Figure 17. Global Valganciclovir Sales Market Share by Manufacturer in 2020
Figure 18. Global Valganciclovir Revenue Market Share by Manufacturer in 2020
Figure 19. Valganciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Valganciclovir Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Valganciclovir Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Valganciclovir Sales Market Share by Region (2016-2026)
Figure 23. Global Valganciclovir Revenue Market Share by Region (2016-2026)
Figure 24. North America Valganciclovir Revenue (2016-2026) & (USD Million)
Figure 25. Europe Valganciclovir Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Valganciclovir Revenue (2016-2026) & (USD Million)
Figure 27. South America Valganciclovir Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Valganciclovir Revenue (2016-2026) & (USD Million)
Figure 29. Global Valganciclovir Sales Market Share by Type (2016-2026)
Figure 30. Global Valganciclovir Revenue Market Share by Type (2016-2026)
Figure 31. Global Valganciclovir Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Valganciclovir Sales Market Share by Application (2016-2026)
Figure 33. Global Valganciclovir Revenue Market Share by Application (2016-2026)
Figure 34. Global Valganciclovir Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Valganciclovir Sales Market Share by Type (2016-2026)
Figure 36. North America Valganciclovir Sales Market Share by Application (2016-2026)
Figure 37. North America Valganciclovir Sales Market Share by Country (2016-2026)
Figure 38. North America Valganciclovir Revenue Market Share by Country (2016-2026)
Figure 39. United States Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Valganciclovir Sales Market Share by Type (2016-2026)
Figure 43. Europe Valganciclovir Sales Market Share by Application (2016-2026)
Figure 44. Europe Valganciclovir Sales Market Share by Country (2016-2026)
Figure 45. Europe Valganciclovir Revenue Market Share by Country (2016-2026)
Figure 46. Germany Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Valganciclovir Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Valganciclovir Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Valganciclovir Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Valganciclovir Revenue Market Share by Region (2016-2026)
Figure 55. China Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Valganciclovir Sales Market Share by Type (2016-2026)
Figure 62. South America Valganciclovir Sales Market Share by Application (2016-2026)
Figure 63. South America Valganciclovir Sales Market Share by Country (2016-2026)
Figure 64. South America Valganciclovir Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Valganciclovir Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Valganciclovir Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Valganciclovir Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Valganciclovir Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Valganciclovir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
子ども用カルシウムサプリメントの世界市場2018-2025 Calcium is the essential building block of bones and teeth, Children Calcium Tablet can provide daily calcium volume to children.In 2018, the global Children Calcium supplement market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study,…- 世界のデフェラシロクス錠市場 2021：企業別、地域別、種類・用途別 The Deferasirox Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のチニダゾール錠剤市場 2021：企業別、地域別、種類・用途別 The Tinidazole Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界のブリグチニブ錠市場 2021：企業別、地域別、種類・用途別 The Brigatinib Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の成人用人工内耳市場 2021：企業別、地域別、種類・用途別 The Cochlear Implants for Adults market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…